Dr. Joshua K. Meisner

After completing medical school at the University of Rochester School of Medicine and Dentistry, where he was inducted into Alpha Omega Alpha and Gold Humanism honor societies, Dr. Zampi completed his residency training at Children’s National Medical Center in Washington DC. Dr. Zampi then completed his fellowship training in pediatric cardiology at the University of Michigan, which he followed with an additional year of subspecialty training in interventional pediatric cardiology. Dr. Zampi is now an Assistant Professor of Pediatrics within the University of Michigan Congenital Heart Center. He focuses on interventional pediatric cardiology and cardiac critical care.Dr. Zampi’s main research interests include novel interventional approaches in congenital heart disease, including hybrid procedures and percutaneous valve implantation. He is also interested in neurodevelopment and neurocognitive function in patients with congenital heart disease. In addition, Dr. Zampi has taken a lead role in quality improvement efforts within the cardiac catheterization laboratory and is involved in several national data registries to improve the care of patients who undergo cardiac catheterization procedures within the Congenital Heart Center. Dr. Zampi is highly rated in 25 conditions, according to our data. His top areas of expertise are Tetralogy of Fallot, Hypoplastic Left Heart Syndrome (HLHS), Coarctation of the Aorta, Stent Placement, and Angioplasty.

Dr. Dorfman was born and raised in southeast Michigan, and returned home in 2007 after training and working as faculty at Children’s Hospital Boston and Harvard Medical School. He is co-director of congenital and pediatric cardiovascular magnetic resonance imaging and attends in the echocardiography laboratory, as well as seeing patients in a general pediatric cardiology clinic. Dr. Dorfman is highly rated in 48 conditions, according to our data. His top areas of expertise are Tetralogy of Fallot, Double Discordia, Transposition of the Great Arteries, and Hypoplastic Left Heart Syndrome (HLHS).

Mark W.Russell, M.D. is a board certified Pediatric Cardiologist with a busy clinical practice and research program. Dr. Russell provides the Pediatric Cardiology services for the Hypertrophic Cardiomypathy Program and the Multidisciplinary Muscular Dystrophy Clinic. He directs clinical research studies examining the effect of genetic factors on post-operative outcomes and is the site principal investigator for a multicenter, clinical trial evaluating a new potential treatment for protein-losing enteropathy. He is the director of a biorepository for a multicenter clinical trial sponsored by the Pediatric Heart Network and is a member of the Heart Network's panel that oversees the acquisition and study of biologic samples from patients with congenital heart defects. In addition, he directs a busy laboratory that examines the effects of the extracellular environment on the differentiation of immature cells into cardiac myocytes. Dr. Russell is highly rated in 105 conditions, according to our data. His top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Congenital Heart Disease (CHD), Hypoplastic Left Heart Syndrome (HLHS), and Patent Foramen Ovale Repair.